Navigation Links
Childhood Influenza Immunization Coalition Applauds Expanded Influenza Vaccine Recommendation for Children
Date:2/27/2008

All children 6 months to 18 years of age recommended for annual vaccination

ATLANTA, Feb. 27 /PRNewswire/ -- The National Foundation for Infectious Diseases' Childhood Influenza Immunization Coalition (CIIC) is pleased to support today's vote by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) to expand the influenza vaccine recommendation for children 6 months up to 18 years of age. This recommendation is to be implemented as soon as feasible and no later than the 2009/10 influenza season.

"Each season many children remain vulnerable to the consequences of not being vaccinated against influenza," said Richard H. Carmona, M.D., M.P.H., FACS, CIIC Chair, 17th Surgeon General of the United States (2002-2006), President of Canyon Ranch Institute and Distinguished Professor of Public Health, The University of Arizona Mel and Enid Zuckerman College of Public Health. "We hope this expanded vaccination recommendation will strongly encourage Americans to get an annual influenza vaccination as soon as vaccine becomes available in their communities. This will help in reducing the number of childhood hospitalizations and deaths from influenza each season."

Influenza is a serious and potentially deadly disease that spreads very easily. Anyone can get influenza, but rates of infection are highest among children. Currently, the recommendation calls for annual vaccination of children 6 months up to 5 years of age. Vaccination is especially beneficial to both children and adults with certain chronic medical conditions like asthma, diabetes, heart disease and compromised immune systems. Not only are children at risk for influenza when unvaccinated, but infected children often transmit influenza to other vulnerable populations, such as grandparents and other caregivers age 50 and over. An expanded vaccination recommendation means greater protection for children and for the community at large.

"The Coalition welcomes ACIP's recommendation as we continue to educate the health care community and the general public about the severity of influenza," said Carol J. Baker, M.D., FAAP, FIDSA, CIIC Moderator, NFID President and Professor of Pediatrics, Molecular Virology and Microbiology, Baylor College of Medicine. "Influenza is very serious, but it is vaccine- preventable. Annual vaccination of children of all ages is the best way to protect children and interrupt virus transmission to others."

A Coalition report available on http://www.PreventChildhoodInfluenza.org outlines key strategies for health care professionals to help ensure all recommended children are vaccinated: offering influenza vaccination at all medical visits and making use of the entire influenza season -- vaccinating as soon as vaccine is available and continuing to vaccinate in January, February and beyond.

About the Childhood Influenza Immunization Coalition

The National Foundation for Infectious Diseases' (NFID) Childhood Influenza Immunization Coalition (CIIC) was established to protect infants, children and adolescents from influenza by communicating with "one strong voice" the need to make influenza immunization a national health priority. CIIC members represent 25 of the nation's leading public health, medical, patient and parent groups committed to protecting children's health and encouraging wellness.

The Childhood Influenza Immunization Coalition initiatives are made possible through an unrestricted educational grant to NFID from sanofi pasteur.

For more information on CIIC or childhood influenza, please visit http://www.preventchildhoodinfluenza.org.

Contact: Jennifer Corrigan

732-382-8898

732-742-7148 (Cell phone)


'/>"/>
SOURCE The National Foundation for Infectious Diseases
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases
2. NIH Funds Vaccine Research for Needle-free and Self-Administered Protection Against Pandemic Influenza
3. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
4. Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference
5. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
6. Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated
7. Vical Presentation at Military Pandemic Influenza Workshop
8. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
9. Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
10. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
11. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... prevention of migraine at the American Academy of Neurology ... 2017, in Boston . ... safety and patient outcomes data for galcanezumab in patients ... monthly migraine headache days among patients with episodic migraine. ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... scientific and clinical research community’s growing body of knowledge during its Eighth ... Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, graduate students, ...
(Date:4/20/2017)... 20, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: ... the International Liver Congress ("ILC") 2017 of the European Association ... Amsterdam on the positive effects of PBI-4050 on ... obesity and metabolic syndrome. ... According to Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of ...
(Date:4/20/2017)... ... 20, 2017 , ... Parallel6™ , the leader in mClinical™ technologies for ... were named one of the 2017 Top 10 eClinical Trial Management Solution Providers ... industry. , “We take pride in honoring Parallel6 as one of the top 10 ...
Breaking Biology Technology:
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/16/2017)... 2017 CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity ... Used combined in one project, multi-biometric ... ...
(Date:3/9/2017)... Australia , March 9, 2017 /PRNewswire/ ... at the prestigious World Lung Imaging Workshop at the ... Fouras , was invited to deliver the latest data ... This globally recognised event brings together leaders at the ... latest developments in lung imaging. "The ...
Breaking Biology News(10 mins):